Sanofi India issues regulatory filing under SEBI norms
Sanofi India issues regulatory filing under SEBI norms. The company has submitted an intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is a routine disclosure with no specific financial figures or strategic announcements. Traders should monitor for follow-up updates.
📊 STOCKS: $SANOFI | 🏢 SECTOR: Pharma | #LOWIMPACT #Regulatory
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.
Next articlegold prices surge amid global uncertainty